Prefrontal cortical gamma-aminobutyric acid transmission and cognitive function: Drawing links to schizophrenia from preclinical research

Biological Psychiatry

Volumn 77, Issue 11, 2015, Pages 929-939

  Tse, Maric T ^a   Piantadosi, Patrick T ^a   Floresco, Stan B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal models; Attention; Cognitive deficits; Cognitive flexibility; GABA; Prefrontal cortex; Schizophrenia; Working memory

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; BEHAVIOR; COGNITION; COGNITIVE DEFECT; EMOTION; GABAERGIC TRANSMISSION; GENETIC MODEL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SALIENCE NETWORK; SCHIZOPHRENIA; WORKING MEMORY; ANIMAL; COGNITION DISORDERS; COMPLICATION; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; COGNITION DISORDERS; GAMMA-AMINOBUTYRIC ACID; HUMANS; PREFRONTAL CORTEX; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84929179951     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.09.007     Document Type: Review

References (127)

1. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 1996 321 330
2. M. Laruelle, A. Abi-Dargham, C.H. Van Dyck, R. Gil, C.D. D'Souza, and J. Erdos Single photon emission computerized tomography imaging of schizophrenic subjects Proc Natl Acad Sci U S A 93 1996 9235 9240
3. A. Abi-Dargham, R. Gil, J. Krystal, R.M. Baldwin, J.P. Seibyl, and M. Bowers Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort Am J Psychiatry 155 1998 761 767
4. A. Reichenberg, A. Caspi, H. Harrington, R. Houts, R.S.E. Keefe, and R.M. Murray Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study Am J Psychiatry 167 2010 160 169
5. R.S. Keefe, S.G. Silva, D.O. Perkins, and J.A. Lieberman The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis Schizophr Bull 25 1999 201 222
6. S. Akbarian, J.J. Kim, S.G. Potkin, J.O. Hagman, A. Tafazzoli, W.E. Bunney, and E.G. Jones Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics Arch Gen Psychiatry 52 1995 258 266
7. T. Hashimoto, H.H. Bazmi, K. Mirnics, Q. Wu, A.R. Sampson, and D.A. Lewis Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia Am J Psychiatry 165 2008 479 489
8. S.J. Fung, M.J. Webster, S. Sivagnanasundaram, C. Duncan, M. Elashoff, and C.S. Weickert Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia Am J Psychiatry 167 2010 1479 1488
9. T. Hashimoto, D.W. Volk, S.M. Eggan, K. Mirnics, J.N. Pierri, and Z. Sun Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia J Neurosci 23 2003 6315 6326
10. A. Guidotti, J. Auta, J. Davis, V. Gerevini, Y. Dwivedi, and D.R. Grayson Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study Arch Gen Psychiatry 57 2000 1061 1069
11. M. Thompson, C.S. Weickert, E. Wyatt, and M.J. Webster Decreased glutamic acid decarboxylase 67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders J Psychiatr Res 43 2009 970 977
12. D.A. Lewis, and G. González-Burgos Neuroplasticity of neocortical circuits in schizophrenia Neuropsychopharmacology 33 2008 141 165
13. V.S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth Parvalbumin neurons and gamma rhythms enhance cortical circuit performance Nature 459 2009 698 702
14. M. Carlén, K. Meletis, J.H. Siegle, J.A. Cardin, K. Futai, and D. Vierling-Claassen A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior Mol Psychiatry 17 2011 1 12
15. M. Beneyto, A. Abbott, T. Hashimoto, and D.A. Lewis Lamina-specific alterations in cortical GABAA receptor subunit expression in schizophrenia Cereb Cortex 21 2011 999 1011
16. C. Haenschel, R.A. Bittner, J. Waltz, F. Haertling, M. Wibral, and W. Singer Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia J Neurosci 29 2009 9481 9489
17. L.M. Rowland, K. Kontson, J. West, R.A. Edden, H. Zhu, and S.A. Wijtenburg In vivo measurements of glutamate, GABA, and NAAG in schizophrenia Schizophr Bull 39 2013 1096 1104
18. H. Silver, and P. Feldman Evidence for sustained attention and working memory in schizophrenia sharing a common mechanism J Neuropsychiatry Clin Neurosci 17 2005 391 398
19. N. Goto, R. Yoshimura, S. Kakeda, J. Moriya, K. Hayashi, and A. Ikenouchi-Sugita Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia Hum Psychopharmacol 24 2009 639 645
20. Z.J. Daskalakis, B.K. Christensen, R. Chen, P.B. Fitzgerald, R.B. Zipursky, and S. Kapur Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation Arch Gen Psychiatry 59 2002 347 354
21. L.S. Kegeles, X. Mao, A.D. Stanford, R. Girgis, N. Ojeil, and X. Xu Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy Arch Gen Psychiatry 69 2012 1 11
22. D. Ongür, A.P. Prescot, J. McCarthy, B.M. Cohen, and P.F. Renshaw Elevated gamma-aminobutyric acid levels in chronic schizophrenia Biol Psychiatry 68 2010 667 670
23. O.A.C. Petroff GABA and glutamate in the human brain Neurosci 8 2002 562 573
24. D.R. Weinberger, K.F. Berman, and R.F. Zec Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia Arch Gen Psychiatry 43 1986 114 124
25. M.J. Minzenberg, A.R. Laird, S. Thelen, C.S. Carter, and D.C. Glahn Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia Arch Gen Psychiatry 66 2009 811 822
26. M. Pezze, S. McGarrity, R. Mason, K.C. Fone, and T. Bast Too little and too much: Hypoactivation and disinhibition of medial prefrontal cortex cause attentional deficits J Neurosci 34 2014 7931 7946
27. D. Attwell, and C. Iadecola The neural basis of functional brain imaging signals Trends Neurosci 25 2002 621 625
28. N.K. Logothetis, J. Pauls, M. Augath, T. Trinath, and A. Oeltermann Neurophysiological investigation of the basis of the fMRI signal Nature 412 2001 150 157
29. N.K. Logothetis, and B.A. Wandell Interpreting the BOLD signal Annu Rev Physiol 66 2004 735 769
30. J. Coyle NMDA receptor and schizophrenia: A brief history Schizophr Bull 38 2012 920 926
31. B. Moghaddam, and J.H. Krystal Capturing the angel in "angel dust": Twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans Schizophr Bull 38 2012 942 949
32. B. Moghaddam, and D. Javitt From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment Neuropsychopharmacology 37 2011 4 15
33. J. Lisman Excitation, inhibition, local oscillations, or large-scale loops: What causes the symptoms of schizophrenia? Curr Opin Neurobiol 22 2012 537 544
34. P. O'Donnell Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia Eur J Neurosci 35 2012 1866 1870
35. P.R.A. Stokes, J.F. Myers, N.J. Kalk, B.J. Watson, D. Erritzoe, and S.J. Wilson Acute increases in synaptic GABA detectable in the living human brain: A [(11)C]Ro15-4513 PET study Neuroimage 99 2014 158 165
36. B. Rudy, G. Fishell, S. Lee, and J. Hjerling-Leffler Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons Dev Neurobiol 71 2011 45 61
37. F. Conde, J.S. Lund, D.M. Jacobowitz, K.G. Baimbrldge, and D.A. Lewis Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: Distribution and morphology J Comp Neurol 116 1994 95 116
38. N.V. Povysheva, A.V. Zaitsev, D.C. Rotaru, G. Gonzalez-Burgos, D.A. Lewis, and L.S. Krimer Parvalbumin-positive basket interneurons in monkey and rat prefrontal cortex J Neurophysiol 100 2008 2348 2360
39. A. Brown Prenatal infection as a risk factor for schizophrenia Schizophr Bull 32 2006 200 202
40. J. Richetto, F. Calabrese, M.A. Riva, and U. Meyer Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome Schizophr Bull 40 2014 351 361
41. D.J. Lodge, M.M. Behrens, and A.A. Grace A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia J Neurosci 29 2009 2344 2354
42. B.K. Lipska, D.N. Lerman, Z.Z. Khaing, C.S. Weickert, and D.R. Weinberger Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs Eur J Neurosci 18 2003 391 402
43. J. François, A. Ferrandon, E. Koning, M.-J. Angst, G. Sandner, and A. Nehlig Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats Int J Neuropsychopharmacol 12 2009 1097 1110
44. K.Y. Tseng, F. Amin, B.L. Lewis, and P. O'Donnell Altered prefrontal cortical metabolic response to mesocortical activation in adult animals with a neonatal ventral hippocampal lesion Biol Psychiatry 60 2006 585 590
45. P. O'Donnell, B.L. Lewis, D.R. Weinberger, and B.K. Lipska Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats Cereb Cortex 12 2002 975 982
46. Z.J. Huang, G. Di Cristo, and F. Ango Development of GABA innervation in the cerebral and cerebellar cortices Nat Rev Neurosci 8 2007 673 686
47. R.T. Ryan, S.K. Bhardwaj, Y.C. Tse, L.K. Srivastava, and T.P. Wong Opposing alterations in excitation and inhibition of layer 5 medial prefrontal cortex pyramidal neurons following neonatal ventral hippocampal lesion Cereb Cortex 23 2013 1198 1207
48. B. Esmaeili, and A.A. Grace Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: Evidence for interneuron dysfunction Neuropsychopharmacology 38 2013 1871 1880
49. A.J. Gruber, G.G. Calhoon, I. Shusterman, G. Schoenbaum, M.R. Roesch, and P. O'Donnell More is less: A disinhibited prefrontal cortex impairs cognitive flexibility J Neurosci 30 2010 17102 17110
50. S.Y.T. Cherlyn, P.S. Woon, J.J. Liu, W.Y. Ong, G.C. Tsai, and K. Sim Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance Neurosci Biobehav Rev 34 2010 958 977
51. E. Rossignol Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders Neural Plast 2011 2011 1 25
52. D. St Clair, D. Blackwood, W. Muir, A. Carothers, M. Walker, and G. Spowart Association within a family of balanced autosomal translocation with major mental illness Lancet 336 1990 13 16
53. S. Shen, B. Lang, C. Nakamoto, F. Zhang, J. Pu, and S.-L. Kuan Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1 J Neurosci 28 2008 10893 10904
54. F.H.F. Lee, C.C. Zai, S.P. Cordes, J.C. Roder, and A.H.C. Wong Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice Mol Brain 6 2013 1 10
55. T. Hikida, H. Jaaro-Peled, S. Seshadri, K. Oishi, C. Hookway, and S. Kong Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans Proc Natl Acad Sci U S A 104 2007 14501 14506
56. M. Niwa, A. Kamiya, R. Murai, K. Kubo, A.J. Gruber, and K. Tomita Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits Neuron 65 2010 480 489
57. S.B. Powell, T.J. Sejnowski, and M.M. Behrens Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia Neuropharmacology 62 2011 1322 13231
58. K.Q. Do, A.H. Trabesinger, M. Kirsten-Krüger, C.J. Lauer, U. Dydak, and D. Hell Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo Eur J Neurosci 12 2000 3721 3728
59. R. Gysin, R. Kraftsik, J. Sandell, P. Bovet, C. Chappuis, and P. Conus Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence Proc Natl Acad Sci U S A 104 2007 16621 16626
60. A. Ballesteros, P. Jiang, A. Summerfelt, X. Du, J. Chiappelli, and P. O'Donnell No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia Schizophr Res 146 2013 184 189
61. J.-H. Cabungcal, D. Nicolas, R. Kraftsik, M. Cuénod, K.Q. Do, and J.-P. Hornung Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia Neurobiol Dis 22 2006 624 637
62. J. Cabungcal, P. Steullet, and R. Kraftsik Early-life insults impair parvalbumin interneurons via oxidative stress: Reversal by N-Acetylcysteine Biol Psychiatry 73 2013 574 582
63. J.-H. Cabungcal, P. Steullet, H. Morishita, R. Kraftsik, M. Cuenod, T.K. Hensch, and K.Q. Do Perineuronal nets protect fast-spiking interneurons against oxidative stress Proc Natl Acad Sci U S A 110 2013 9130 9135
64. J. Krystal, L. Karper, J. Seibyl, G. Freeman, R. Delaney, and J. Brenner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
65. A.C. Lahti, M.A. Weiler, T. Michaelidis, A. Parwani, and C.A. Tamminga Effects of ketamine in normal and schizophrenic volunteers Neuropsychopharmacology 25 2001 455 467
66. M.M. Morshedi, and G.E. Meredith Differential laminar effects of amphetamine on prefrontal parvalbumin interneurons Neuroscience 149 2007 617 624
67. D. Peleg-Raibstein, I. Knuesel, and J. Feldon Amphetamine sensitization in rats as an animal model of schizophrenia Behav Brain Res 191 2008 190 201
68. M. Tse, A. Cantor, and S. Floresco Repeated amphetamine exposure disrupts dopaminergic modulation of amygdala-prefrontal circuitry and cognitive/emotional functioning J Neurosci 31 2011 11282 11294
69. M. Behrens, S. Ali, D. Dao, and J. Lucero Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase Science 318 2007 1645 1647
70. J.P. Redrobe, L. Elster, K. Frederiksen, C. Bundgaard, I.E.M. de Jong, and G.P. Smith Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats Psychopharmacology (Berl) 221 2012 451 468
71. D.R. Thomases, D.K. Cass, and K.Y. Tseng Periadolescent exposure to the NMDA receptor antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the adult prefrontal cortex J Neurosci 33 2013 26 34
72. M.M. Behrens, S.S. Ali, and L.L. Dugan Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia J Neurosci 28 2008 13957 13966
73. H. Homayoun, and B. Moghaddam NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons J Neurosci 27 2007 11496 11500
74. C.Z. Wang, S.F. Yang, Y. Xia, and K.M. Johnson Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons Neuropsychopharmacology 33 2008 2442 2455
75. J.W. Olney, J.W. Newcomer, and N.B. Farber NMDA receptor hypofunction model of schizophrenia J Psychiatr Res 33 1999 523 533
76. S.K. Asinof, and T.A. Paine Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task Neuropharmacology 65 2013 39 47
77. T.A. Paine, L.E. Slipp, and W.A. Carlezon Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors Neuropsychopharmacology 36 2011 1703 1713
78. A.L. Pehrson, C.O. Bondi, N.K.B. Totah, and B. Moghaddam The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention Psychopharmacology (Berl) 225 2013 31 39
79. T.W. Robbins The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry Psychopharmacology (Berl) 163 2002 362 380
80. N.S. Gray, and R.J. Snowden The relevance of irrelevance to schizophrenia Neurosci Biobehav Rev 29 2005 989 999
81. S. Kapur Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia Am J Psychiatry 160 2003 13 23
82. I. Weiner The "two-headed" latent inhibition model of schizophrenia: Modeling positive and negative symptoms and their treatment Psychopharmacology (Berl) 169 2003 257 297
83. D. Joel, I. Weiner, and J. Feldon Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: Implications for animal models of schizophrenia Behav Brain Res 85 1997 187 201
84. L. Lacroix, S. Spinelli, W. White, and J. Feldon The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion Neuroscience 97 2000 459 468
85. P.T. Piantadosi, and S.B. Floresco Prefrontal cortical GABA transmission modulates discrimination and latent inhibition of conditioned fear: Relevance for schizophrenia Neuropsychopharmacology 39 2014 2473 2484
86. T. Sawaguchi, M. Matsumura, and K. Kubota Delayed response deficit in monkeys by locally disturbed prefrontal neuronal activity by bicuculline Behav Brain Res 31 1988 193 198
87. T. Sawaguchi, M. Matsumura, and K. Kubota Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys Exp Brain Res 75 1989 457 469
88. S.G. Rao, G.V. Williams, and P.S. Goldman-Rakic Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory J Neurosci 20 2000 485 494
89. T. Enomoto, M.T. Tse, and S.B. Floresco Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia Biol Psychiatry 69 2011 432 441
90. S.B. Floresco, J.K. Seamans, and A.G. Phillips Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay J Neurosci 17 1997 1880 1890
91. J.K. Seamans, S.B. Floresco, and A.G. Phillips Functional differences between the prelimbic and anterior cingulate regions of the rat prefrontal cortex Behav Neurosci 109 1995 1063 1073
92. C.Z. Burton, L. Vella, P.D. Harvey, T.L. Patterson, R.K. Heaton, and E.W. Twamley Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia Schizophr Res 146 2013 244 248
93. K.H. Nuechterlein, D.M. Barch, J.M. Gold, T.E. Goldberg, M.F. Green, and R.K. Heaton Identification of separable cognitive factors in schizophrenia Schizophr Res 72 2004 29 39
94. C. Pantelis, S.J. Wood, T.M. Proffitt, R. Testa, K. Mahony, and W.J. Brewer Attentional set-shifting ability in first-episode and established schizophrenia: Relationship to working memory Schizophr Res 112 2009 104 113
95. J.M. Rodríguez-Sánchez, B. Crespo-Facorro, C. González-Blanch, R. Perez-Iglesias, and J.L. Vázquez-Barquero Cognitive dysfunction in first-episode psychosis: The processing speed hypothesis Br J Psychiatry Suppl 51 2007 s107 s110
96. C. Pantelis, F.Z. Barber, T.R.E. Barnes, H.E. Nelson, A.M. Owen, and T.W. Robbins Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage Schizophr Res 37 1999 251 270
97. S.B. Floresco, A.E. Block, and M.T.L. Tse Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal learning, using a novel, automated procedure Behav Brain Res 190 2008 85 96
98. S.B. Floresco, Y. Zhang, and T. Enomoto Neural circuits subserving behavioral flexibility and their relevance to schizophrenia Behav Brain Res 204 2009 396 409
99. G.B. Bissonette, G. Schoenbaum, M.R. Roesch, and E.M. Powell Interneurons are necessary for coordinated activity during reversal learning in orbitofrontal cortex [published online ahead of print Aug 1] Biol Psychiatry. 2014
100. C-SR Li Do schizophrenia patients make more perseverative than non-perseverative errors on the Wisconsin Card Sorting Test? A meta-analytic study Psychiatry Res 129 2004 179 190
101. M. Hartman, M.C. Steketee, S. Silva, K. Lanning, and C. Andersson Wisconsin Card Sorting Test performance in schizophrenia: The role of working memory Schizophr Res 63 2003 201 217
102. J. Jensen, M. Willeit, R. Zipursky, I. Savina, A.J. Smith, and M. Menon The formation of abnormal associations in schizophrenia: Neural and behavioral evidence Neuropsychopharmacology 33 2008 473 479
103. L. Palaniyappan, and P.F. Liddle Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction J Psychiatry Neurosci 37 2012 17 27
104. F. Sotres-Bayon, and G.J. Quirk Prefrontal control of fear: More than just extinction Curr Opin Neurobiol 20 2010 231 235
105. P.T. Piantadosi, and S.B. Floresco Regulation of discriminative fear conditioning by distinct prefrontal cortical subregions Soc Neurosci Abstr 2014 746
106. S.R. Sesack, and A.A. Grace Cortico-basal ganglia reward network: Microcircuitry Neuropsychopharmacology 35 2010 27 47
107. D.J. Lodge The medial prefrontal and orbitofrontal cortices differentially regulate dopamine system function Neuropsychopharmacology 36 2011 1227 1236
108. S. Murase, J. Grenhoff, G. Chouvet, F.G. Gonon, and T.H. Svensson Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo Neurosci Lett 157 1993 53 56
109. K. Ahn, R. Gil, J. Seibyl, R.A. Sewell, and D.C. D'Souza Probing GABA receptor function in schizophrenia with iomazenil Neuropsychopharmacology 36 2011 677 683
110. D.A. Lewis, R.Y. Cho, C.S. Carter, K. Eklund, S. Forster, M.A. Kelly, and D. Montrose Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia Am J Psychiatry 165 2008 1585 1593
111. R.W. Buchanan, R.S.E. Keefe, J.A. Lieberman, D.M. Barch, J.G. Csernansky, and D.C. Goff A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia Biol Psychiatry 69 2011 442 449
112. J. Richetto, F. Calabrese, U. Meyer, and M.A. Riva Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice Brain Behav Immun 33 2013 190 200
113. Y. Zhang, B.N. Cazakoff, C.A. Thai, and J.G. Howland Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats Neuropharmacology 62 2012 1299 1307
114. L. Zuckerman, M. Rehavi, R. Nachman, and I. Weiner Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: A novel neurodevelopmental model of schizophrenia Neuropsychopharmacology 28 2003 1778 1789
115. R. Gourevitch, C. Rocher, G L.e. Pen, M.-O. Krebs, and T.M. Jay Working memory deficits in adult rats after prenatal disruption of neurogenesis Behav Pharmacol 15 2004 287 292
116. H. Moore, J.D. Jentsch, M. Ghajarnia, M.A. Geyer, and A.A. Grace A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: Implications for the neuropathology of schizophrenia Biol Psychiatry 60 2006 253 264
117. P. Flagstad, B.Y. Glenthøj, and M. Didriksen Cognitive deficits caused by late gestational disruption of neurogenesis in rats: A preclinical model of schizophrenia Neuropsychopharmacology 30 2005 250 260
118. A.M. Brady, R.D. Saul, and M.K. Wiest Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia Neuropharmacology 59 2010 605 611
119. A.M. Brady Neonatal ventral hippocampal lesions disrupt set-shifting ability in adult rats Behav Brain Res 205 2009 294 298
120. A.W. Johnson, H. Jaaro-Peled, N. Shahani, T.W. Sedlak, S. Zoubovsky, and D. Burruss Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness Proc Natl Acad Sci U S A 110 2013 12462 12467
121. J.-H. Cabungcal, D. Preissmann, C. Delseth, M. Cuénod, K.Q. Do, and F. Schenk Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: Relevance to schizophrenia Neurobiol Dis 26 2007 634 645
122. R.E. Featherstone, S. Kapur, and P.J. Fletcher The amphetamine-induced sensitized state as a model of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1556 1571
123. P.J. Fletcher, C.C. Tenn, Z. Rizos, V. Lovic, and S. Kapur Sensitization to amphetamine, but not PCP, impairs attentional set shifting: Reversal by a D1 receptor agonist injected into the medial prefrontal cortex Psychopharmacology (Berl) 183 2005 190 200
124. C.C. Tenn, S. Kapur, and P.J. Fletcher Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition Psychopharmacology (Berl) 180 2005 366 376
125. N. Amitai, and A. Markou Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment Pharmacol Biochem Behav 93 2009 248 257
126. T. Enomoto, and S.B. Floresco Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure Prog Neuropsychopharmacol Biol Psychiatry 33 2009 668 675
127. P. Goetghebeur, and R. Dias Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat - a back translational study Psychopharmacology (Berl) 202 2009 287 293